| scholarly article | Q13442814 |
| P50 | author | Franz Fazekas | Q43184302 |
| Michael Khalil | Q57021488 | ||
| Christian Langkammer | Q87769278 | ||
| P2093 | author name string | R. Schmidt | |
| S. Fuchs | |||
| C. Enzinger | |||
| K. Petrovic | |||
| M. Tscherner | |||
| M. Wallner-Blazek | |||
| M. Loitfelder | |||
| M. Jehna | |||
| G. Bachmaier | |||
| S. Ropele | |||
| P2860 | cites work | Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) | Q22241644 |
| Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” | Q22252938 | ||
| Cognitive impairment in probable multiple sclerosis | Q24672050 | ||
| Cognitive dysfunction in multiple sclerosis: a review of recent developments | Q28186881 | ||
| Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction | Q28276538 | ||
| Cognitive impairment in multiple sclerosis | Q28300777 | ||
| Differential diagnosis of suspected multiple sclerosis: a consensus approach | Q29039412 | ||
| Advances in functional and structural MR image analysis and implementation as FSL | Q29547164 | ||
| Improved optimization for the robust and accurate linear registration and motion correction of brain images | Q29547542 | ||
| Fast robust automated brain extraction | Q29615078 | ||
| A global optimisation method for robust affine registration of brain images | Q29615079 | ||
| Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. | Q31038381 | ||
| Cognitive changes in multiple sclerosis | Q33377548 | ||
| Magnetization transfer MR imaging in multiple sclerosis | Q33390856 | ||
| Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study | Q33591681 | ||
| Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis | Q35455319 | ||
| Cognitive changes in early MS: a call for a common framework. | Q36458762 | ||
| Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis | Q38399474 | ||
| Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm | Q39512850 | ||
| Cognitive impairment in different MS subtypes and clinically isolated syndromes | Q43714152 | ||
| Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients | Q44471617 | ||
| Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. | Q44785506 | ||
| Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes | Q45214546 | ||
| Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. | Q48109147 | ||
| Widespread cortical thinning characterizes patients with MS with mild cognitive impairment. | Q48333484 | ||
| Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis | Q48423353 | ||
| Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis | Q48459611 | ||
| Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis | Q48760113 | ||
| Cognitive abnormalities in multiple sclerosis: a psychometric and MRI study | Q48798566 | ||
| Evaluating sub-clinical cognitive dysfunction and event-related potentials (P300) in clinically isolated syndrome. | Q48831135 | ||
| Cognitive impairment and structural brain damage in benign multiple sclerosis. | Q48910232 | ||
| [Normalization of the Brief Repeatable Battery of Neuropsychological tests (BRB-N) for German-speaking regions. Application in relapsing-remitting and secondary progressive multiple sclerosis patients]. | Q52000857 | ||
| The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice. | Q52017450 | ||
| Cognitive dysfunction in multiple sclerosis.: II. Impact on employment and social functioning | Q67896534 | ||
| Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment | Q80332818 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cognition | Q2200417 |
| cognitive dysfunction | Q57859955 | ||
| P304 | page(s) | 173-180 | |
| P577 | publication date | 2010-10-18 | |
| P1433 | published in | Multiple Sclerosis Journal | Q1952449 |
| P1476 | title | Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome | |
| P478 | volume | 17 |
| Q91642009 | Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options |
| Q36840016 | CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome |
| Q52144830 | Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis. |
| Q64070095 | Cognitive Impairment in Multiple Sclerosis With Regards to Disease Duration and Clinical Phenotypes |
| Q50898780 | Cognitive Impairment in Multiple Sclerosis. |
| Q51859117 | Cognitive impairment and MS: searching for effective therapies. |
| Q48380147 | Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis |
| Q48546465 | Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis |
| Q30814336 | Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis. |
| Q51140016 | Extensive white matter dysfunction in cognitively impaired patients with secondary-progressive multiple sclerosis. |
| Q30768942 | Gray matters in multiple sclerosis: cognitive impairment and structural MRI. |
| Q38840386 | Information processing speed in multiple sclerosis: Past, present, and future |
| Q57069382 | Is impaired information processing speed a matter of structural or functional damage in MS? |
| Q30597559 | New magnetic resonance imaging biomarkers for the diagnosis of multiple sclerosis. |
| Q35221948 | Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis |
| Q37704428 | Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study. |
| Q41780757 | Regional gray matter atrophy and neuropsychologcal problems in relapsing-remitting multiple sclerosis |
| Q33553474 | Relationship between working hours and power of attention, memory, fatigue, depression and self-efficacy one year after diagnosis of clinically isolated syndrome and relapsing remitting multiple sclerosis |
| Q46043515 | Reports of patients and relatives from the CogniCIS study about cognition in clinically isolated syndrome: what are our patients telling us? |
| Q48168382 | The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials |
| Q38211996 | The prognostic utility of MRI in clinically isolated syndrome: a literature review. |
| Q31033345 | The role of MRI in the evaluation of secondary progressive multiple sclerosis. |
| Q38181064 | Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010 |
| Q48654549 | Utility of neuropsychological testing for guiding treatment decisions in paediatric multiple sclerosis. |
| Q39635811 | Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis |
Search more.